Sign in to continue:

Wednesday, July 29th, 2026

包头东宝生物2026年东宝转债付息公告及利率信息披露

东宝生物2026年可转债付息公告详解

东宝生物发布2026年可转换公司债券付息公告,投资者需重点关注

一、公告要点

  • 债券名称与代码:东宝转债(123214)
  • 2026年第三年利息支付:每10张(面值1,000元)利息10.00元(含税),付息日为2026年7月31日。
  • 债权登记日及除息日:债权登记日为2026年7月30日,除息日为2026年7月31日。
  • 本次计息期间及利率:2025年7月31日至2026年7月30日,票面利率1.00%。
  • 下一计息期利率:自2026年7月31日起,利率提升至1.50%。
  • 发行情况:2023年7月31日发行4,550,000张,2023年8月18日上市,存续期至2029年7月30日。
  • 信用评级:公司主体及可转债均为A+,评级展望稳定。
  • 税务事项:个人投资者和基金需缴纳20%利息所得税,由券商代扣代缴,QFII/RQFII等合格境外投资者利息暂免所得税和增值税。
  • 转股注意事项:在付息债权登记日前(含登记日)转股的投资者,不再享受当年度及以后年度利息。

二、对投资者和股东的潜在影响

  • 利息支付带来的影响:本次付息将为债券持有人带来稳定现金流,增强东宝转债的吸引力,有助于提升债券投资者信心,对公司整体资本市场形象具有正面效应。
  • 票面利率逐年提升:2026年后,票面利率升至1.50%,未来逐年递增至2.50%,有望进一步提升转债投资吸引力,可能吸引更多资金关注。
  • 转股窗口开启:2024年2月5日至2029年7月30日期间可转股,若市场对公司股票前景看好,或将推动转债转股需求,影响公司股本结构和股价表现。
  • 信用评级稳定:A+的主体及债券评级,显示公司信用状况良好,有助于增强投资者信心,提升转债及正股的市场认可度。
  • 税务政策利好外资:2026-2027年期间合格境外投资者利息暂免所得税和增值税,或吸引更多外资参与,提升流动性和关注度。
  • 转股与付息冲突提示:投资者若在登记日前转股,将不可再领取本计息年度及以后年度利息,需注意相关操作时机,避免利益损失。

三、详细付息安排

  • 债权登记日:2026年7月30日,持有人需在此日收市前持有东宝转债才能享有本次利息。
  • 付息日:2026年7月31日,公司将通过中国结算深圳分公司完成利息划付。
  • 兑付流程:中国结算深圳分公司收到利息资金后,将通过资金结算系统划拨至各证券公司营业部或认可机构。
  • 税后收益:个人投资者和基金每10张可得8元(税后);QFII/RQFII及其他非居民企业暂免税,获得10元;其他债券持有者自行纳税。

四、投资者特别提示

  • 本公告所涉及的付息与转股安排,均可能影响投资者的投资回报及操作时机,建议密切关注相关日期。
  • 由于债券票面利率逐年提升,转债的价值有望随公司基本面改善、市场利率变化及股价表现而波动,建议投资者结合市场环境和自身需求理性决策。
  • 如有疑问可联系公司证券部,电话:0472-6208676,邮箱:[email protected]

五、总结

东宝转债2026年度付息公告明确了第三年利息支付安排、债权登记及除息时间、利率调整和税务政策,对债券持有人和潜在投资者均有重要参考价值。随着票面利率逐年提升和外资税收政策利好,东宝转债的市场吸引力有望进一步增强,对公司股价及资本市场表现具有正面潜力,值得关注。


免责声明:本文仅为公开信息解读,不构成任何投资建议。投资存在风险,投资者须根据自身情况审慎决策。


English Version
Detailed Analysis: Dongbao BioTech 2026 Convertible Bond Interest Payment Notice

Key Points and Investor Impact of Dongbao Biotech’s 2026 Convertible Bond Interest Payment Announcement

1. Key Highlights

  • Bond Name & Code: Dongbao Convertible Bond (123214)
  • 2026 Third-Year Interest Payment: Interest of RMB 10.00 (pre-tax) per 10 bonds (face value RMB 1,000), payable on July 31, 2026.
  • Record Date and Ex-Interest Date: Record date is July 30, 2026; ex-interest date is July 31, 2026.
  • Interest Period & Rate: From July 31, 2025, to July 30, 2026, coupon rate is 1.00%.
  • Next Interest Rate: Rises to 1.50% starting July 31, 2026.
  • Issuance Details: 4,550,000 bonds issued on July 31, 2023; listed August 18, 2023; matures July 30, 2029.
  • Credit Rating: Both company and bond are rated A+ with a stable outlook.
  • Taxation: Individual and fund holders subject to 20% interest income tax withheld by brokers; QFII/RQFII and other eligible foreign investors temporarily exempt from income tax and VAT.
  • Conversion Note: Those converting bonds to stock on or before the record date are not entitled to the interest for the current or subsequent years.

2. Potential Impact on Investors and Shareholders

  • Stable Cash Flow: The interest payment provides stable cash flow to bondholders, boosting the bond’s attractiveness and investor confidence.
  • Rising Coupon Rate: Annual coupon rate increases (up to 2.50% in later years) may draw more investors and support bond pricing.
  • Conversion Window: Bond conversion into shares is open from February 5, 2024, to July 30, 2029. Positive equity sentiment could drive conversions, impacting share structure and price.
  • Stable Credit Profile: The A+ rating underlines the company’s solid credit status, supporting positive market sentiment for both bonds and shares.
  • Overseas Tax Policy: The tax exemption for eligible foreign investors (2026-2027) could attract more foreign capital and improve liquidity.
  • Conversion vs. Interest: Investors should note that converting before the record date forfeits interest rights for the current and future years; timing is crucial.

3. Detailed Payment Arrangements

  • Record Date: July 30, 2026—investors must hold bonds through this date to receive interest.
  • Payment Date: July 31, 2026. Payment is processed via China Securities Depository and Clearing Corporation (Shenzhen Branch).
  • Net Yields: Individuals/funds receive RMB 8 (after 20% withholding) per 10 bonds; QFII/RQFII and nonresident enterprises receive RMB 10 (tax-exempt); other holders must handle their own tax filing.

4. Special Reminders for Investors

  • Interest and conversion arrangements may impact investment returns and strategies; investors should closely monitor relevant dates.
  • With rising coupon rates and potential tax advantages, the bond’s value may fluctuate with market conditions and company performance.
  • For inquiries, contact Dongbao’s securities department at 0472-6208676 or [email protected].

5. Conclusion

This notice clarifies Dongbao Convertible Bond’s 2026 interest payment, record and ex-interest dates, rate adjustments, and tax treatments. With incremental rate rises and favorable foreign investor tax policies, the bond’s market appeal stands to increase, potentially benefiting both bondholders and shareholders.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should assess their own risk tolerance and seek professional guidance as needed.


View 东宝生物 Historical chart here



紫光国芯微电子2025年度利润分配方案公告:每10股派现3.10元 含分红比例与合理性说明

紫光国芯微电子股份有限公司披露2025年度利润分配方案,分红及回购总额占净利32.04% 紫光国芯微电子股份有限公司...

江西煌上煌控股股东一致行动人完成3%股份减持,持股降至63.3%【2026年最新公告】

煌上煌控股股东一致行动人减持股份计划完成,股权比例降至63.3% 煌上煌控股股东一致行动人减持股份计划完成,股权比例...

江苏常宝钢管股份有限公司2025年度权益分派实施公告:每10股派2元现金红利方案详情

常宝股份2025年度权益分派实施公告详解 常宝股份发布2025年度权益分派实施公告,派息细节公布 重点内容摘要 分...